Familial essential thrombocythemia: Clinical characteristics of 11 cases in one family - Annals of Hematology
- ️Eikenboom, J. C. J.
- ️Tue Mar 01 1994
References
Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 58:2440–2447
Buss DH, Stuart JJ, Lipscomb GE (1985) The incidence of thrombotic and hemorrhagic disorders in associaton with extreme thrombocytosis: an analysis of 129 cases. Am J Hematol 20:365–372
Colombi M, Radaelli F, Zocchi L, Maiolo AT (1991) Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients. Cancer 67:2926–2930
Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 8:556–562
Dodsworth H (1980) Primary thrombocythaemia in monozygotic twins. Br Med J 280:1506
Eyster ME, Saletan SL, Rabellino EM, Karanas A, McDonald TP, Locke LA, Luderer JR (1986) Familial essential thrombocythemia. Am J Med 80:497–502
Fabris F, Casonato A, Grazia Del Ben M, De Marco L, Girolami A (1986) Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. Br J Haematol 63:75–83
Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549–556
Fernandez-Robles E, Vermylen C, Martiat P, Ninane J, Cornu G (1990) Familial essential thrombocythemia. Pediatr Hematol Oncol 7:373–376
Fickers M, Speck B (1974) Thrombocythaemia. Familial occurrence and transition into blastic crisis. Acta Haematol 51:257–265
Geller SA, Shapiro E (1982) Acute leukemia as a natural sequel to primary thrombocythemia. Am J Clin Pathol 77:353–356
Genderen PJJ van, Michiels JJ (1993) Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann Hematol 67:57–62
Grossi A, Rosseti S, Vannucchi AM, Rafanelli D, Ferrini PR (1988) Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients. Clin Lab Haematol 10:167–175
Hehlmann R, Jahn M, Baumann B, Köpcke W (1988) Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 61:2487–2496
Janssen JWG, Anger BR, Drexler HG, Bartram CR, Heimpel H (1990) Essential thrombocythemia in two sisters originating from different stem cell levels. Blood 75:1633–1636
Kessler CM, Klein HG, Havlik RJ (1982) Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol 50:157–167
Lahuerta-Palacios JJ, Bornstein R, Fernández-Debora FJ, Gutiérrez-Rivas E, Ortiz MC, Larregla S, Calandre L, Montero-Castillo J (1988) Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemia. Cancer 61:1207–1212
McCallum CJ, Peake IR, Newcombe RG, Bloom AL (1983) Factor VIII levels and blood group antigens. Thromb Haemost 50:757
McIntyre KJ, Hoagland HC, Silverstein MN, Petitt RM (1991) Essential thrombocythemia in young adults. Mayo Clin Proc 66:149–154
Michiels JJ, Abels J, Steketee J, van Vliet HHDM, Vuzevski VD (1985) Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 102:466–471
Michiels JJ, Koudstaal PJ, Mulder AH, van Vliet HHDM (1993) Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology 43:1107–1110
Millard FE, Hunter CS, Anderson M, Edelman MJ, Kosty MP, Luiken GA, Marino GG (1990) Clinical manifestations of essential thrombocythemia in yound adults. Am J Hematol 33:27–31
Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI (1990) Hemostatic complications in young patients with essential thrombocythemia. Am J Med 88:371–375
Mohri H, Asada H, Kodama F, Itoh A, Ohkubo T (1986) Platelet dysfunction in patients with essential thrombocythemia: acquired von Willebrand's disease. Acta Haematol Jpn 49:1418–1426
Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23:177–182
Peake IR, Bowen D, Bignell P, Liddell MB, Sadler JE, Standen G, Bloom AL (1990) Family studies and prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction amplification of a variable number tandem repeat region of the von Willebrand factor gene. Blood 76:555–561
Pette JEW van de, Prochazka AV, Pearson TC, Singh AK, Dickson ER, Wetherley-Mein G (1986) Primary thrombocythaemia treated with busulphan. Br J Haematol 62:229–237
Ploos van Amstel HK, Reitsma PH (1990) Tetranucleotide repeat polymorphism in the vWF gene. Nucleic Acids Res 18:4957
Preston FE (1983) Aspirin, prostaglandins, and peripheral gangrene. Am J Med 74 [Suppl]:55–60
Preston AE, Barr A (1964) The plasma concentration of factor VIII in the normal population. II. The effects of age, sex and blood group. Br J Haematol 10:238–245
Randi ML, Stocco F, Rossi C, Tison T, Girolami A (1991) Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). J Med 22:213–223
Sato K (1988) Plasma von Willebrand factor abnormalities in patients with essential thrombocythemia. Keio J Med 37:54–71
Schafer AI (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64:1–12
Scheffer MG, Michiels JJ, Simoons ML, Roelandt JRTC (1991) Thrombocythemia and coronary artery disease. Am Heart J 122:573–576
Seabright M (1971) A rapid banding technique for human chromosomes. Lancet 2:971–972
Sessarego M, Defferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, Ajmar F (1989) Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study. Cancer Genet Cytogenet 43:57–65
Slee PHTJ, van Everdingen JJ, Geraedts JPM, te Velde J, den Ottolander GJ (1981) Familial myeloproliferative disease. Hematological and cytogenetic studies. Acta Med Scand 210:321–327
Tatewaki W, Takahashi H, Shibata A (1988) Multimeric composition of plasma von Willebrand factor in chronic myeloproliferative disorders. Clin Lab Haematol 10:417–425
Tobelem G (1989) Essential thrombocythaemia. Ballieres Clin Haematol 2:719–728
Webber LM, Garson OM (1983) Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 8:123–132
Wehmeier A, Daum I, Jamin H, Schneider W (1991) Incidence and clinical risk faktors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hematol 63:101–106
Williams EC, Shahidi NT (1991) Benign familial thrombocytosis. Am J Hematol 37:124–125